Kezar Life Sciences, Inc. Banner Image

Kezar Life Sciences, Inc.

  • Ticker KZR
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Kezar Life Sciences, Inc. Logo Image
  • 11-50 Employees
  • Based in South San Francisco, California
Based in South San Francisco, Kezar Life Sciences is combining courage, conviction and cutting-edge science to develop breakthrough treatments for immune-mediated and oncologic disorders. The company is pioneering first-in-class, small-molecule therapies that harness master regulators of cellular function and inhibit multiple drivers of disease via a single target. KZR-616, a first-in-classMore selective immunoproteasome inhibitor, is being evaluated in severe and underserved autoimmune diseases. Additionally, KZR-261, the first clinical candidate for the treatment of cancer from the company’s protein secretion program targeting the Sec61 translocon, is undergoing IND-enabling activities.
4.8 / 5.0 (276)

Kezar Life Sciences, Inc. reports have an aggregate usefulness score of 4.8 based on 276 reviews.

Kezar Life Sciences, Inc.

Most Recent Annual Report

Kezar Life Sciences, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Kezar Life Sciences, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!